Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2020 Filed Jan 31, 2020 19:54 UTC |
Morgan Sandra L.SVP-Provider Relations
|
GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005898 · doc4.xml · derivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:49 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantStock Appreciation Right · Derivative | 11,040 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005897 · doc4.xml · derivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,040 Underlying: Common Stock · 11,040 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:48 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005896 · doc4.xml · derivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:47 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
GrantStock Appreciation Right · Derivative | 22,080 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005895 · doc4.xml · derivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,080 Underlying: Common Stock · 22,080 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantStock Appreciation Right · Derivative | 13,800 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · derivative · entry 7 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Underlying: Common Stock · 13,800 shares Expires 2030-01-29 F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 45,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Tax withholdingCommon Stock | 23,691 | $145.24 | $3,440,880.84 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,955 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Exercise / conversionCommon Stock | 45,000 | $37.18 | $1,673,100.00 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
SaleCommon Stock | 31,063 | $145.30 | $4,513,488.07 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.66 to $145.96, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:47 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
GrantStock Appreciation Right · Derivative | 11,040 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005894 · doc4.xml · derivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,040 Underlying: Common Stock · 11,040 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:44 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005891 · doc4.xml · derivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:43 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
GrantStock Appreciation Right · Derivative | 22,080 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005890 · doc4.xml · derivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,080 Underlying: Common Stock · 22,080 shares Expires 2030-01-29 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:43 UTC |
Paslick P. MartinSVP and CIO
|
GrantStock Appreciation Right · Derivative | 16,560 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005889 · doc4.xml · derivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,560 Underlying: Common Stock · 16,560 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:42 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005888 · doc4.xml · derivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:37 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantStock Appreciation Right · Derivative | 22,080 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005883 · doc4.xml · derivative · entry 7 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,080 Underlying: Common Stock · 22,080 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:37 UTC | GrantStock Appreciation Right · Derivative | 172,490 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005882 · doc4.xml · derivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,490 Underlying: Common Stock · 172,490 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
|
| January 29, 2020 Filed Jan 31, 2020 19:36 UTC |
Foster Jon MGroup President
|
GrantStock Appreciation Right · Derivative | 35,880 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005879 · doc4.xml · derivative · entry 6 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,880 Underlying: Common Stock · 35,880 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:35 UTC |
Cuffe Michael S.President-Physician Services
|
GrantStock Appreciation Right · Derivative | 22,080 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005877 · doc4.xml · derivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,080 Underlying: Common Stock · 22,080 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:35 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GrantStock Appreciation Right · Derivative | 11,040 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005878 · doc4.xml · derivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,040 Underlying: Common Stock · 11,040 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:34 UTC |
Cohen Jeffrey E.SVP-Government Relations
|
GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005876 · doc4.xml · derivative · entry 1 Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:33 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
GrantStock Appreciation Right · Derivative | 13,800 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005873 · doc4.xml · derivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Underlying: Common Stock · 13,800 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:34 UTC |
Billington Phillip GSVP-Internal Audit Services
|
GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005875 · doc4.xml · derivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| December 24, 2019 Filed Dec 26, 2019 17:02 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 4,164 | $148.56 | $618,603.84 |
DisclosureSEC source: 0001209191-19-061976 · doc4.xml · nonDerivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 23, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 5,891 | $147.04 | $866,212.64 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · nonDerivative · entry 5 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,193.2078 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,853.2078 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionStock Appreciation Right · Derivative | 20,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · derivative · entry 7 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 13,541 | $147.53 | $1,997,703.73 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · nonDerivative · entry 4 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,084.2078 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,853.2078 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 20,000 | $68.96 | $1,379,200.00 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · nonDerivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,625.2078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,853.2078 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:03 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 60,654 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,654 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:03 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Tax withholdingCommon Stock | 29,591 | $147.53 | $4,365,560.23 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,709 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:03 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Exercise / conversionCommon Stock | 60,654 | $22.95 | $1,392,009.30 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:02 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 10,175 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-19-061976 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Stock · 10,175 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:02 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 6,011 | $147.53 | $886,802.83 |
DisclosureSEC source: 0001209191-19-061976 · doc4.xml · nonDerivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,164 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:02 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 10,175 | $47.97 | $488,094.75 |
DisclosureSEC source: 0001209191-19-061976 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:01 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 4,550 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-061973 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,550 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:01 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 2,487 | $147.53 | $366,907.11 |
DisclosureSEC source: 0001209191-19-061973 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,543 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:01 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionCommon Stock | 4,550 | $37.18 | $169,169.00 |
DisclosureSEC source: 0001209191-19-061973 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionStock Appreciation Right · Derivative | 14,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · derivative · entry 6 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 8,609 | $145.39 | $1,251,662.51 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,625.2078 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,853.2078 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 16:52 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 14,500 | $47.97 | $695,565.00 |
DisclosureSEC source: 0001209191-19-061816 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,234.2078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,853.2078 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 17:05 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 2,049 | $143.50 | $294,031.50 |
DisclosureSEC source: 0001209191-19-060241 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 2,100 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · derivative · entry 4 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,550 Underlying: Common Stock · 2,100 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 2,450 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,450 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 2,501 | $144.61 | $361,669.61 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,529 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionCommon Stock | 4,550 | $37.18 | $169,169.00 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 19, 2019 Filed Jan 31, 2020 19:45 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005892 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Indirect · By BNR LLC Disclosed balance after: 40,000 F1 · ownership.nature: The reported securities are held by a limited liability company. On February 1, 2019, the reporting person contributed 40,000 shares of common stock of HCA Healthcare, Inc. to the limited liability company. The reporting person was the sole member of the limited liability company on the date of the initial contribution. On November 19, 2019, the reporting person transferred 100% of his interests in the limited liability company to a family trust of which his spouse is the trustee. Read SEC document |
| November 19, 2019 Filed Jan 31, 2020 19:45 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005892 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Indirect · By BNR LLC Disclosed balance after: 40,000 F1 · ownership.nature: The reported securities are held by a limited liability company. On February 1, 2019, the reporting person contributed 40,000 shares of common stock of HCA Healthcare, Inc. to the limited liability company. The reporting person was the sole member of the limited liability company on the date of the initial contribution. On November 19, 2019, the reporting person transferred 100% of his interests in the limited liability company to a family trust of which his spouse is the trustee. Read SEC document |
| November 19, 2019 Filed Jan 31, 2020 19:36 UTC |
Hall Charles JGroup President
|
GiftCommon Stock | 7,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005881 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,974 Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 14,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · derivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,875 Underlying: Common Stock · 14,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 52,250 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,250 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 55,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.